NeuroVice is a medical device company built on a simple belief: seizure patients deserve better than “do nothing.”

We created PATI (Protector Against Tongue Injury)—the first and only FDA-cleared, prescription rescue device specifically designed to provide oral protection for seizure patients. PATI protects teeth, shields the tongue, and keeps the airway clear. It is indicated for seizure types that may cause oral injury in patients aged 12 and older and is available now.

Nearly one in five epilepsy patients suffer oral injuries during seizures. For decades, the standard of care—while well-intentioned—was to put nothing in a patient’s mouth. PATI changes that, providing a safe, clinically validated solution backed by FDA clearance.

NeuroVice was founded by Dr. Ashlyn Sanders, a Johns Hopkins pediatric neurology resident who experienced seizures following brain surgery. She didn’t just study the problem—Dr. Sanders lived it firsthand and then built a solution that can protect millions from suffering helplessly from preventable injuries.

PATI is used in hospitals, EMS, schools, homes, and public facilities, and is available through BlinkRx and specialty pharmacy distributors.


NeuroVice

Org chart

Teams

Offices

NeuroVice

Org chart

Teams

Offices

Related companies